|
EP300 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30339999968332E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17460000007108E-07 |
| Normal-vs-Stage2 |
3.244700E-03 |
| Normal-vs-Stage3 |
5.786200E-04 |
| Normal-vs-Stage4 |
7.56279999958309E-07 |
| Stage1-vs-Stage2 |
5.111800E-01 |
| Stage1-vs-Stage3 |
6.644000E-01 |
| Stage1-vs-Stage4 |
4.002000E-02 |
| Stage2-vs-Stage3 |
7.891400E-01 |
| Stage2-vs-Stage4 |
5.759900E-02 |
| Stage3-vs-Stage4 |
8.180100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96649999950615E-07 |
| Normal-vs-AfricanAmerican |
4.92870000001755E-06 |
| Normal-vs-Asian |
1.196670E-03 |
| Caucasian-vs-AfricanAmerican |
8.819800E-01 |
| Caucasian-vs-Asian |
6.435000E-01 |
| AfricanAmerican-vs-Asian |
6.220600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.90190000204771E-08 |
| Normal-vs-Female |
4.959600E-03 |
| Male-vs-Female |
4.458400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.6822999999474E-06 |
| Normal-vs-Extreme_Weight |
3.96520000167655E-08 |
| Normal-vs-Obese |
4.977800E-04 |
| Normal-vs-Extreme_Obese |
1.028240E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.973200E-01 |
| Normal_Weight-vs-Obese |
1.377760E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.297400E-01 |
| Extreme_Weight-vs-Obese |
3.654200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.144200E-01 |
| Obese-vs-Extreme_Obese |
2.038600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.021700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.027700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.12979999800089E-08 |
| Normal-vs-Age(81-100Yrs) |
2.10219999996486E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.516800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.283600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.882100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.378460E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.407700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.166800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.78760000036205E-07 |
| Normal-VS-Type2 PRCC |
3.30260000014349E-07 |
| Normal-VS-KIRP CIMP |
1.798480E-02 |
| Normal-VS-Unclassified PRCC |
1.341660E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.098800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.766600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.635800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.052200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.691500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.297400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.23469999674586E-08 |
| Normal-vs-N1 |
2.099200E-03 |
| Normal-vs-N2 |
1.24669999990168E-07 |
| N0-vs-N1 |
2.492200E-01 |
| N0-vs-N2 |
4.552800E-01 |
| N1-vs-N2 |
1.128160E-01 |
|
|
